Immunotherapy of Cancer

An Innovative Treatment Comes of Age

Häftad, Engelska, 2018

2 169 kr

Beställningsvara. Skickas inom 10-15 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

This timely book, published just as cancer immunotherapy comes of age, summarizes the rationale, present status, and future perspective for cancer immunotherapy.

Produktinformation

Utgivningsdatum2018-04-07
Mått155 x 235 x 19 mm
Vikt624 g
FormatHäftad
SpråkEngelska
Antal sidor358
FörlagSpringer Verlag, Japan
ISBN9784431566397

Tillhör följande kategorier

Onkologi inom Medicin

Part I Overview, History, Classification.- Chapter 1 Overview of Current Cancer Immunotherapy.- Part II BRMs and Crude Agents.- Chapter 2 Bacterial Preparations.- Chapter 3 Polysaccharides.- Chapter 4 BCG.- Part III Cytokines.- Chapter 5 αβ-T Cells.- Chapter 6 NKT Cell-Based Immunotherapy.- Chapter 7 Natural Killer Cells.- Chapter 8 γδ T Cell-Based Cancer Immunotherapy.- Chapter 9 Genetically engineered T cells.- Part IV Vaccine Therapy.- Chapter 10 Peptide Vaccine.- Chapter 11 Personalized Peptide Vaccine.- Chapter 12 WT1 Peptide Vaccine for the Treatment of Malignancies.- Chapter 13 Protein vaccine.- Chapter 14 Dendritic Cell-Based Vaccine for Cancer.- Part V Immunoadjuvants.- Chapter 15 CpG Motif.- Chapter 16 Pattern Recognition by Dendritic Cells and Its Application to Vaccine Adjuvant for Antitumor Immunotherapy.- Chapter 17 Novel Adjuvants.- Part VI Immunocheckpoints.- Chapter 18 Anti-CTLA-4 Ab.- Chapter 19 Anti-PD-1, PD-L1 Ab.- Chapter 20 Novel Targets of Immune Inhibitory and Stimulatory Co-signals.- Part VII Regulation of Immunosuppression.- Chapter 21 Regulatory T Cells.- Chapter 22 MDSC: Myeloid-Derived Suppressor Cells.- Part VIII Immune-Related Response Criteria and Guidance for Clinical Trials.- Chapter 23 Immune-Related Response Criteria and Guidance for Clinical Trials.- Part IX Personalized Immunotherapy.- Chapter 24 ersonalized cancer immunotherapy: Immune biomarkers and combination immunotherapy.